BTSG · BrightSpring Health Services, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-25 | ROUSSEAU JON B |
Director, See Remarks |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of the Issuer's common stock withheld by the Issuer to satisfy withholding taxes due in connection with the vesting of 125,012 restricted stock units at a net settlement price equal to the closing stock price on July 24, 2026. |
Common Stock
|
56,319 |
| 2026-06-20 | Greenwell Scott A. |
President, PharMerica |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of the Issuer's common stock withheld by the Issuer to satisfy withholding taxes due in connection with the vesting of 5,613 restricted stock units at a net settlement price equal to the closing stock price on June 18, 2026. |
Common Stock
|
2,487 |
| 2026-06-11 | Shah Nigam H. |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-11 | Shah Nigam H. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On June 11, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on the earlier of (i) June 11, 2027 and (ii) the day before the Issuer's 2027 annual meeting of stockholders. Each RSU represents a contingent right to receive one share of common stock upon settlement. |
Common Stock
|
4,013 |
| 2026-06-05 | ROUSSEAU JON B |
Director, See Remarks |
Convert↑
|
Common Stock
|
130,000 |
| 2026-06-05 | KKR Group Partnership L.P. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
The price of $58.453 represents the net price received per share of common stock of BrightSpring Health Services, Inc. for shares sold pursuant to an underwritten public offering. Represents securities held by KKR Phoenix Aggregator L.P. KKR Phoenix Aggregator GP LLC is the general partner of KKR Phoenix Aggregator L.P. KKR Americas Fund XII L.P. is the sole member of KKR Phoenix Aggregator GP LLC. KKR Associates Americas XII L.P. is the general partner of KKR Americas Fund XII L.P. KKR Americas XII Limited is the general partner of KKR Associates Americas XII L.P. KKR Group Partnership L.P. is the sole shareholder of KKR Americas XII Limited. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
Common Stock
(I)
|
14,669,771 |
| 2026-06-05 | Nalley Lisa A |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions. |
Common Stock
|
35,000 |
| 2026-06-05 | Nalley Lisa A |
See Remarks |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
These options are fully vested. |
Stock Options (Right to Buy)
|
35,000 |
| 2026-06-05 | KKR Phoenix Aggregator L.P. |
10% Owner |
Gift↓
Filing footnotes — Common Stock (Indirect)
Represents the donation by Mr. Roberts of shares received in the in-kind distribution described in footnote (4) above. |
Common Stock
(I)
|
23,263 |
| 2026-06-05 | ROUSSEAU JON B |
Director, See Remarks |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
These options are fully vested. |
Stock Options (Right to Buy)
|
130,000 |
| 2026-06-05 | Phipps Jennifer A |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
These options are fully vested. |
Stock Options (Right to Buy)
|
35,000 |
| 2026-06-05 | ROUSSEAU JON B |
Director, See Remarks |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Indirect)
These options are fully vested. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Stock Options (Right to Buy)
(I)
|
130,000 |
| 2026-06-05 | KKR Phoenix Aggregator L.P. |
10% Owner |
Other↓
Filing footnotes — Common Stock (Indirect)
Represents distributions of such shares in connection with the sale reported herein by KKR Phoenix Aggregator L.P. and certain of its affiliates to their respective partners and shareholders as in-kind distributions. These in-kind distributions are for the purpose of the ultimate recipients making charitable donations of shares of common stock. Represents securities held by KKR Phoenix Aggregator L.P. KKR Phoenix Aggregator GP LLC is the general partner of KKR Phoenix Aggregator L.P. KKR Americas Fund XII L.P. is the sole member of KKR Phoenix Aggregator GP LLC. KKR Associates Americas XII L.P. is the general partner of KKR Americas Fund XII L.P. KKR Americas XII Limited is the general partner of KKR Associates Americas XII L.P. KKR Group Partnership L.P. is the sole shareholder of KKR Americas XII Limited. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
Common Stock
(I)
|
324,608 |
| 2026-06-05 | Phipps Jennifer A |
Chief Financial Officer |
Convert↑
|
Common Stock
|
35,000 |
| 2026-06-05 | KKR Group Partnership L.P. |
10% Owner |
Gift↓
Filing footnotes — Common Stock (Indirect)
Represents the donation by Mr. Kravis of shares received in the in-kind distribution described in footnote (4) above. |
Common Stock
(I)
|
36,927 |
| 2026-06-05 | KKR Phoenix Aggregator L.P. |
10% Owner |
Gift↓
Filing footnotes — Common Stock (Indirect)
Represents the donation by Mr. Kravis of shares received in the in-kind distribution described in footnote (4) above. |
Common Stock
(I)
|
36,927 |
| 2026-06-05 | Phipps Jennifer A |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions. |
Common Stock
|
35,000 |
| 2026-06-05 | KKR Phoenix Aggregator L.P. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
The price of $58.453 represents the net price received per share of common stock of BrightSpring Health Services, Inc. for shares sold pursuant to an underwritten public offering. Represents securities held by KKR Phoenix Aggregator L.P. KKR Phoenix Aggregator GP LLC is the general partner of KKR Phoenix Aggregator L.P. KKR Americas Fund XII L.P. is the sole member of KKR Phoenix Aggregator GP LLC. KKR Associates Americas XII L.P. is the general partner of KKR Americas Fund XII L.P. KKR Americas XII Limited is the general partner of KKR Associates Americas XII L.P. KKR Group Partnership L.P. is the sole shareholder of KKR Americas XII Limited. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
Common Stock
(I)
|
14,669,771 |
| 2026-06-05 | ROUSSEAU JON B |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Indirect)
These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
130,000 |
| 2026-06-05 | Nalley Lisa A |
See Remarks |
Convert↑
|
Common Stock
|
35,000 |
| 2026-06-05 | KKR Group Partnership L.P. |
10% Owner |
Gift↓
Filing footnotes — Common Stock (Indirect)
Represents the donation by Mr. Roberts of shares received in the in-kind distribution described in footnote (4) above. |
Common Stock
(I)
|
23,263 |
| 2026-06-05 | ROUSSEAU JON B |
Director, See Remarks |
Convert↑
Filing footnotes — Common Stock (Indirect)
The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
130,000 |
| 2026-06-05 | KKR Group Partnership L.P. |
10% Owner |
Other↓
Filing footnotes — Common Stock (Indirect)
Represents distributions of such shares in connection with the sale reported herein by KKR Phoenix Aggregator L.P. and certain of its affiliates to their respective partners and shareholders as in-kind distributions. These in-kind distributions are for the purpose of the ultimate recipients making charitable donations of shares of common stock. Represents securities held by KKR Phoenix Aggregator L.P. KKR Phoenix Aggregator GP LLC is the general partner of KKR Phoenix Aggregator L.P. KKR Americas Fund XII L.P. is the sole member of KKR Phoenix Aggregator GP LLC. KKR Associates Americas XII L.P. is the general partner of KKR Americas Fund XII L.P. KKR Americas XII Limited is the general partner of KKR Associates Americas XII L.P. KKR Group Partnership L.P. is the sole shareholder of KKR Americas XII Limited. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
Common Stock
(I)
|
324,608 |
| 2026-06-05 | ROUSSEAU JON B |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions. |
Common Stock
|
130,000 |
| 2026-05-05 | KIRTLEY OLIVIA F |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. |
Common Stock
|
4,983 |
| 2026-05-05 | Wicks Timothy A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election. |
Common Stock
|
4,983 |
| 2026-05-05 | Miller Steven B |
EVP, Chief Clinical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. |
Common Stock
|
4,983 |
| 2026-04-25 | ROUSSEAU JON B |
Director, See Remarks |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of the Issuer's common stock withheld by the Issuer to satisfy withholding taxes due in connection with the vesting of 125,012 restricted stock units at a net settlement price equal to the closing stock price on April 24, 2026. |
Common Stock
|
16,222 |
| 2026-03-30 | Barnes Robert Allen |
President, Community Living |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of the Issuer's common stock withheld by the Issuer to satisfy withholding taxes due in connection with the vesting of 15,540 restricted stock units at a net settlement price equal to the closing stock price on March 30, 2026. |
Common Stock
|
6,748 |
| 2026-03-20 | ROUSSEAU JON B |
Director, See Remarks |
Gift↑
Filing footnotes — Stock Options (Right to Buy) (Indirect)
Represents a bona fide gift by the Reporting Person's spouse to The Margaret Rousseau Children Trust. These options are fully vested. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Stock Options (Right to Buy)
(I)
|
192,704 |
| 2026-03-20 | ROUSSEAU JON B |
Director, See Remarks |
Gift↓
Filing footnotes — Stock Options (Right to Buy) (Indirect)
Represents a bona fide gift by the Reporting Person's spouse to The Margaret Rousseau Children Trust. These options are fully vested. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Stock Options (Right to Buy)
(I)
|
192,704 |
| 2026-03-20 | ROUSSEAU JON B |
Director, See Remarks |
Gift↑
Filing footnotes — Stock Options (Right to Buy) (Indirect)
Represents a bona fide gift by the Reporting Person to the Reporting Person's spouse. These options are fully vested. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Stock Options (Right to Buy)
(I)
|
192,704 |
| 2026-03-20 | ROUSSEAU JON B |
Director, See Remarks |
Gift↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
Represents a bona fide gift by the Reporting Person to the Reporting Person's spouse. These options are fully vested. |
Stock Options (Right to Buy)
|
192,704 |
| 2026-03-20 | ROUSSEAU JON B |
Director, See Remarks |
Gift↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
Represents a bona fide gift by the Reporting Person to the Rousseau Family Trust. These options are fully vested. |
Stock Options (Right to Buy)
|
180,753 |
| 2026-03-20 | ROUSSEAU JON B |
Director, See Remarks |
Gift↑
Filing footnotes — Stock Options (Right to Buy) (Indirect)
Represents a bona fide gift by the Reporting Person to the Rousseau Family Trust. These options are fully vested. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. |
Stock Options (Right to Buy)
(I)
|
180,753 |
| 2026-03-05 | Greenwell Scott A. |
President, PharMerica |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Options vest in three equal annual installments commencing on January 25, 2027. |
Stock Options (Right to Buy)
|
49,073 |
| 2026-03-05 | Greenwell Scott A. |
President, PharMerica |
Award↑
Filing footnotes — Common Stock (Direct)
On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement. |
Common Stock
|
20,020 |
| 2026-03-05 | Nalley Lisa A |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement. |
Common Stock
|
21,354 |
| 2026-03-05 | Phipps Jennifer A |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement. |
Common Stock
|
53,384 |
| 2026-03-05 | Phipps Jennifer A |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Options vest in three equal annual installments commencing on January 25, 2027. |
Stock Options (Right to Buy)
|
130,860 |
| 2026-03-05 | Nalley Lisa A |
See Remarks |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Options vest in three equal annual installments commencing on January 25, 2027. |
Stock Options (Right to Buy)
|
52,344 |
| 2026-03-05 | ROUSSEAU JON B |
Director, See Remarks |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Options vest in twelve equal quarterly installments commencing on April 25, 2026. |
Stock Options (Right to Buy)
|
458,008 |
| 2026-03-05 | ROUSSEAU JON B |
Director, See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in twelve equal quarterly installments commencing on April 25, 2026. Each RSU represents a contingent right to receive one share of common stock upon settlement. |
Common Stock
|
186,845 |
| 2026-03-04 | KKR Phoenix Aggregator L.P. |
10% Owner |
Gift↓
Filing footnotes — Common Stock (Indirect)
Represents the donation by Mr. Roberts of shares received in the in-kind distribution described in footnote (4) above. |
Common Stock
(I)
|
31,918 |
| 2026-03-04 | Phipps Jennifer A |
Chief Financial Officer |
Convert↑
|
Common Stock
|
35,000 |
| 2026-03-04 | Nalley Lisa A |
See Remarks |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
These options are fully vested. |
Stock Options (Right to Buy)
|
30,000 |
| 2026-03-04 | Nalley Lisa A |
See Remarks |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested. |
Stock Options (Right to Buy)
|
3,925 |
| 2026-03-04 | Phipps Jennifer A |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested. |
Stock Options (Right to Buy)
|
5,888 |
| 2026-03-04 | Phipps Jennifer A |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested. |
Stock Options (Right to Buy)
|
35,331 |
| 2026-03-04 | Nalley Lisa A |
See Remarks |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested. |
Stock Options (Right to Buy)
|
35,331 |